Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
InSpek logo — Improving the access to therapies through enhanced (bio)proc...

InSpek

Improving the access to therapies through enhanced (bio)process monitoring, with integrated photonic sensors.

Founded 2021 France France 18 employees Seed Total: $4.00M

General Information

Company Name InSpek
Founded Year 2021
Location France France
Employees 18
Funding Stage Seed
Business Model B2B, Platform, SaaS
Revenue Model Subscription, Usage Based, Service Fee
Social

BounceWatch is an independent company data service, not affiliated with InSpek. To contact InSpek, visit inspek-solutions.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does InSpek compare?

A PDF of InSpek and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting InSpek soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About InSpek

InSpek is poised to redefine the field of bio-process monitoring with its cutting-edge integrated photonic sensor technology. Founded in 2021 and headquartered in France, the company aims to enhance the accessibility of therapies, bridging a significant gap in the biopharmaceutical landscape. Its mission is succinctly captured in its slogan: "Improving the access to therapies through enhanced (bio)process monitoring, with integrated photonic sensors."

The venture has already demonstrated substantial promise, securing a €3.50M grant investment as of 01 September 2024. This financial boost underscores confidence from notable investors, including Breega, Quantonation, and Wind. By focusing on the development of revolutionary biological and chemical monitoring systems, InSpek presents a compelling opportunity for investors seeking innovation in the biotech industry. This startup is well-positioned to make significant strides in transforming therapeutic monitoring standards worldwide.

Business keywords: integrated photonics, bioprocess monitoring, chemical monitoring, optical chip technologies, light-matter interactions, chemical detection, biosensor innovation, nanotechnology, micro-optics, sensor technology, therapeutic access, photonics in healthcare, democratizing chemical analysis, biological monitoring systems, advanced sensor integration

Services & Products

Bioprocess monitoring
Chemical reaction monitoring
Process optimization

Target Customers

Biotechnology companies Chemical processing industries Research laboratories

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Grant €3.50M 3
Breega Quantonation Wind
Breega, Quantonation +1
01 Sep 2024
Seed $500.00K 1
Quantonation
Quantonation
01 Jun 2022
Spinout Undisclosed 1
AGORANOV
AGORANOV
01 Oct 2021

Latest News

View All
Paris-based InSpek secures €6 million to accelerate biomanufacturing with photonics — Eu-startups
Paris-based InSpek secures €6 million to accelerate biomanufacturing with photonics
Eu-startups Sep 25, 2024
Quantonation closes first €70m of new fund for quantum startups — Sifted
Quantonation closes first €70m of new fund for quantum startups
Sifted Apr 10, 2024

InSpek Alternatives & Competitors

View All Alternatives
InSpek vs
SmartNanotubes Technologies
SmartNanotubes Technologies Germany

We let machines detect smells

Series A
15 employees
Energy, Manufacturing
InSpek vs
Haydale
Haydale

Creating Material Change

Grant
51 employees
Manufacturing
InSpek vs
Insplorion AB
Insplorion AB Sweden

Hydrogen sensors for accelerated transition to a sustainable future

Grant
19 employees
Autonomous and Sensor Tech
View all alternatives

FAQ About InSpek

Improving the access to therapies through enhanced (bio)process monitoring, with integrated photonic sensors.
InSpek was founded in 2021.
InSpek is headquartered in France.
InSpek has a B2B, Platform and SaaS business model. Its revenue comes from Subscription, Usage Based and Service Fee.
InSpek has approximately 18 employees.
InSpek has completed 3 funding rounds, raising a total of $4.00M. The latest funding stage is Seed.
InSpek offers: Bioprocess monitoring, Chemical reaction monitoring, Process optimization.
Top alternatives and competitors to InSpek include SmartNanotubes Technologies, Haydale, Insplorion AB, Rolling Optics AB, Arborsense, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
InSpek and SmartNanotubes Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for InSpek, https://bouncewatch.com/company/inspek, updated 2 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout